Bio-Rad Laboratories (BIO-B) Accumulated Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Accumulated Expenses data on file, last reported at $148.4 million in Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $148.4 million, down 5.72% year-over-year; the trailing twelve-month figure through Mar 2026 was $148.4 million (down 5.72% YoY), and the FY2025 annual result was $172.3 million, up 38.73% from the prior year.
• Accumulated Expenses retreated to $148.4 million in Q1 2026 per BIO-B's latest filing, from $172.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $194.8 million in Q4 2022 and troughed at $124.2 million in Q4 2024.
• A 5-year average of $161.4 million and a median of $157.4 million in 2025 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2025: Accumulated Expenses declined 29.68% in 2022, then soared 38.73% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $194.8 million in 2022, then decreased by 28.18% to $139.9 million in 2023, then retreated by 11.22% to $124.2 million in 2024, then jumped by 38.73% to $172.3 million in 2025, then dropped by 13.87% to $148.4 million in 2026.
• Business Quant data shows BIO-B's Accumulated Expenses at $148.4 million in Q1 2026, $172.3 million in Q4 2025, and $182.8 million in Q3 2025.